Side-by-side comparison of AI visibility scores, market position, and capabilities
Jakarta Indonesia UTBK university entrance exam preparation platform for 800K+ annual test-takers with live classes and MURI record-setting online tryouts; competing with Ruangguru and Zenius for Indonesia edtech exam prep market leadership.
Pahamify is a Jakarta, Indonesia-based educational technology company — providing Indonesian high school students with comprehensive preparation for the UTBK-SNBT (Seleksi Nasional Berbasis Tes, the Indonesian university entrance examination) through live interactive classes, recorded video lessons, adaptive practice questions, AI-powered learning analytics, and full-length mock exams. Founded in 2018 and holding the MURI (Museum Rekor Indonesia) world record for hosting the largest online tryout exam participation, Pahamify has established itself as one of Indonesia's leading UTBK preparation platforms with hundreds of thousands of student users across the country. The platform serves the approximately 800,000 Indonesian students who take the UTBK-SNBT annually in competition for limited spots at public universities.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.